Karl-Erik Andersson
1 – 10 of 167
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Soluble Guanylate Cyclase Activators to Treat Benign Prostatic Hyperplasia and associated LUTS
(
- Contribution to journal › Scientific review
-
Mark
Targeting neurotrophin and nitric oxide signaling to promote recovery and ameliorate neurogenic bladder dysfunction following spinal cord injury – Mechanistic concepts and clinical implications
(
- Contribution to journal › Scientific review
-
Mark
Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract : Clinical Relevance and Potential for Innovation
(
- Contribution to journal › Scientific review
-
Mark
Molecular and Morphological Characteristics of the De-Obstructed Rat Urinary Bladder—An Update
(
- Contribution to journal › Article
-
Mark
Oxidative Stress and Its Relation to Lower Urinary Tract Symptoms
(
- Contribution to journal › Scientific review
-
Mark
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator
(
- Contribution to journal › Article
-
Mark
Emerging drugs for the treatment of bladder storage dysfunction
(
- Contribution to journal › Scientific review
-
Mark
Changes in the rat urinary bladder after the relief of outflow obstruction – tracing targets for treatment of persistent symptoms in patients
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Re : Systemic Therapy for Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC): Systematic Review of Published Trials in the Last 5 Years
(
- Contribution to journal › Debate/Note/Editorial